Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

'Careful goodbye at the door': is there role for antimicrobial stewardship interventions for antimicrobial therapy prescribed on hospital discharge?

Authors: R. Chavada, J. Davey, L. O’Connor, D. Tong

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Antimicrobial stewardship (AMS) interventions largely target inpatient antimicrobial prescribing. Literature on appropriateness of antimicrobials prescribed at the interface between hospital and the community is minimal. This study was designed to assess the appropriateness of antimicrobials prescribed on hospital discharge and evaluate the impact of AMS interventions.

Methods

Patients with discharge medications processed by the pharmacy were identified using a computerized pharmacy medication tracker over a four week period. The antimicrobials prescribed on discharge were assessed independently for appropriateness of antimicrobial choice, dose, frequency and duration. Data on various AMS interventions was collected. Univariate followed by multivariate logistic regression (MVLR) analysis was performed using SPSS V 23 (IBM, California).

Results

A total of 892 discharge prescriptions were processed by the pharmacy department, 236 of which contained antibiotic prescriptions. Of these, 74% were appropriate for antimicrobial choice, 64% for dose, 64% for frequency and 21% for duration. In particular, 71% of patients received a course in excess of Therapeutic Guidelines-Australia(TG-A) recommended length of treatment. On univariate analysis, discharge antimicrobial prescriptions were more likely to be appropriate for antimicrobial choice, frequency and duration; appropriate microbiological specimens were more likely to be taken and targeted therapy more likely to be given when the AMS team was involved. On MVLR, appropriateness with antimicrobial dosing frequency [OR 5.6(1.9–19.2)], microbiological specimens [OR 4.3(1.6–11.6)] and receipt of targeted therapy [OR 2.8(1.8–6.2)] with AMS involvement remained significant.

Conclusions

A large discrepancy exists between antimicrobial regimens prescribed on hospital discharge and those recommended in consensus guidelines, particularly concerning duration of treatment. While AMS interventions are well established for improving antimicrobial prescribing in hospital inpatients, the hospital-community interface remains a challenge in terms of antimicrobial prescribing and exposes patients to potential harm. There is a clear need for AMS interventions to extend to antimicrobial therapy prescribed on discharge.
Literature
1.
go back to reference de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104.CrossRefPubMedPubMedCentral de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104.CrossRefPubMedPubMedCentral
2.
go back to reference Turnidge JD, Thursky K, Chen CS, McNeil VR, Wilkinson IJ. Antimicrobial use in Australian hospitals: how much and how appropriate? Med J Aust. 2016;205:s16–20.CrossRefPubMed Turnidge JD, Thursky K, Chen CS, McNeil VR, Wilkinson IJ. Antimicrobial use in Australian hospitals: how much and how appropriate? Med J Aust. 2016;205:s16–20.CrossRefPubMed
3.
4.
go back to reference Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol. 2015;36:474–8.CrossRefPubMedPubMedCentral Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol. 2015;36:474–8.CrossRefPubMedPubMedCentral
5.
go back to reference Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society of Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51-e77.CrossRefPubMedCentral Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society of Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51-e77.CrossRefPubMedCentral
7.
go back to reference Chavada R, Walker HN, Tong D, Murray A. Changes in antimicrobial prescribing behaviour after the introduction of the antimicrobial stewardship program: a pre- and post-intervention survey. Infect Dis Rep. 2017;9:7268.CrossRefPubMedPubMedCentral Chavada R, Walker HN, Tong D, Murray A. Changes in antimicrobial prescribing behaviour after the introduction of the antimicrobial stewardship program: a pre- and post-intervention survey. Infect Dis Rep. 2017;9:7268.CrossRefPubMedPubMedCentral
9.
go back to reference Scarpato SJ, Timko DR, Cluzet VC, Dougherty JP, Nunez JJ, Fishman NO, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol. 2017;38:353–5.CrossRefPubMed Scarpato SJ, Timko DR, Cluzet VC, Dougherty JP, Nunez JJ, Fishman NO, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol. 2017;38:353–5.CrossRefPubMed
10.
go back to reference Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, Mehler PS. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol. 2015;36:664–72.CrossRefPubMedPubMedCentral Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, Mehler PS. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol. 2015;36:664–72.CrossRefPubMedPubMedCentral
11.
go back to reference Jenkins TC, Knepper BC, Moore SJ, O’Leary ST, Caldwell B, Saveli CC, Burman WJ. Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection. Infect Control Hosp Epidemiol. 2014;35:1241–50.CrossRefPubMedPubMedCentral Jenkins TC, Knepper BC, Moore SJ, O’Leary ST, Caldwell B, Saveli CC, Burman WJ. Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection. Infect Control Hosp Epidemiol. 2014;35:1241–50.CrossRefPubMedPubMedCentral
12.
go back to reference Howard P, Huttner B, Beovic B, Beraud G, Kofteridis DP, Pano Pardo J, et al. ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey. J Antimicrob Chemother. 2017;72:2910–4.CrossRefPubMed Howard P, Huttner B, Beovic B, Beraud G, Kofteridis DP, Pano Pardo J, et al. ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey. J Antimicrob Chemother. 2017;72:2910–4.CrossRefPubMed
13.
go back to reference Hoover SE. Duration of antibiotics prescribed at hospital discharge. S Dak. J Med. 2017;70:177–8. Hoover SE. Duration of antibiotics prescribed at hospital discharge. S Dak. J Med. 2017;70:177–8.
14.
go back to reference Shea KM, Hobbs ALV, Jaso TC, Bissett JD, Cruz CM, Douglass ET, et al. Effect of a health care system respiratory fluoroquinolone restriction program to Alter utilization and impact rates of Clostridium difficile infection. Antimicrob Agents Chemother. 2017;61:e00125-17.CrossRefPubMedPubMedCentral Shea KM, Hobbs ALV, Jaso TC, Bissett JD, Cruz CM, Douglass ET, et al. Effect of a health care system respiratory fluoroquinolone restriction program to Alter utilization and impact rates of Clostridium difficile infection. Antimicrob Agents Chemother. 2017;61:e00125-17.CrossRefPubMedPubMedCentral
15.
go back to reference Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J Hosp Infect. 2015;91:74–80.CrossRefPubMed Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. J Hosp Infect. 2015;91:74–80.CrossRefPubMed
16.
go back to reference Dumkow LE, Beuschel TS, Brandt KL. Expanding antimicrobial stewardship to urgent care centers through a pharmacist-led culture follow-up program. Infect Dis Ther. 2017;6:453–9.CrossRefPubMedPubMedCentral Dumkow LE, Beuschel TS, Brandt KL. Expanding antimicrobial stewardship to urgent care centers through a pharmacist-led culture follow-up program. Infect Dis Ther. 2017;6:453–9.CrossRefPubMedPubMedCentral
17.
go back to reference Jones JM, Leedahl ND, Losing A, Carson PJ, Leedahl DDA. Pilot study for antimicrobial stewardship post-discharge. J Pharm Pract. 2017:897190017699775. Jones JM, Leedahl ND, Losing A, Carson PJ, Leedahl DDA. Pilot study for antimicrobial stewardship post-discharge. J Pharm Pract. 2017:897190017699775.
18.
go back to reference Caplinger C, Crane K, Wilkin M, Bohan J, Remington R, Madaras-Kelly K. Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge. Am J Hosp Pharm. 2016;73:2043–54. Caplinger C, Crane K, Wilkin M, Bohan J, Remington R, Madaras-Kelly K. Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge. Am J Hosp Pharm. 2016;73:2043–54.
19.
go back to reference Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Antimicrobial stewardship at transition of care from hospital to community. Infect Cont Hosp Epidemiol. 2012;33:401–4.CrossRef Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Antimicrobial stewardship at transition of care from hospital to community. Infect Cont Hosp Epidemiol. 2012;33:401–4.CrossRef
20.
go back to reference Hersh AL, Newland JG, Gerber JS. Pediatric antimicrobial discharge stewardship: an unmet need. JAMA Pediatr. 2016;170:191–2.CrossRefPubMed Hersh AL, Newland JG, Gerber JS. Pediatric antimicrobial discharge stewardship: an unmet need. JAMA Pediatr. 2016;170:191–2.CrossRefPubMed
Metadata
Title
'Careful goodbye at the door': is there role for antimicrobial stewardship interventions for antimicrobial therapy prescribed on hospital discharge?
Authors
R. Chavada
J. Davey
L. O’Connor
D. Tong
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3147-0

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.